Metagenomi, Inc.
MGX
$1.56
-$0.05-2.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.72% | 106.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.72% | 106.28% | |||
| Cost of Revenue | 12.33% | -10.48% | |||
| Gross Profit | -18.79% | 33.41% | |||
| SG&A Expenses | -11.13% | 2.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.77% | -7.66% | |||
| Operating Income | -8.82% | 24.56% | |||
| Income Before Tax | -3.84% | 20.36% | |||
| Income Tax Expenses | -631.82% | -55.10% | |||
| Earnings from Continuing Operations | -2.44% | 20.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.44% | 20.49% | |||
| EBIT | -8.82% | 24.56% | |||
| EBITDA | -9.48% | 25.74% | |||
| EPS Basic | -1.90% | 20.79% | |||
| Normalized Basic EPS | -10.50% | 25.81% | |||
| EPS Diluted | -1.90% | 20.79% | |||
| Normalized Diluted EPS | -10.50% | 25.81% | |||
| Average Basic Shares Outstanding | 0.52% | 0.37% | |||
| Average Diluted Shares Outstanding | 0.52% | 0.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||